Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer

Journal of Urology

Volumn 165, Issue 1, 2001, Pages 84-88

  Vergouwe, Yvonne ^a,b   Steyerberg, Ewout W ^a,b   Foster, Richard S ^a,b   Habbema, J DIK F ^a,b   Donohue, John P ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Histology; Models, statistical; Neoplasm, residual; Testicular neoplasms; Testis

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CHORIONIC GONADOTROPIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RELIABILITY; RETROPERITONEAL CANCER; RETROSPECTIVE STUDY; TESTIS CARCINOMA; TUMOR BIOPSY; TUMOR VOLUME; VALIDATION PROCESS;

EID: 0034749477     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-200101000-00021     Document Type: Article

References (13)

1. Treatment of testicular cancer: A new and improved model
2. The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumor Working Party
3. Evolving concepts in surgical management of testis cancer
4. Outcome analysis of patients with persistent nonteratomous germ cell tumor in post-chemotherapy retroperitoneal lymph node dissections
5. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: Recommendations for patient selection
6. Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer
7. Is post-chemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
8. The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumours
9. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: Multivariate analysis of individual patient data from six study groups
10. Predictors of residual mass histology following chemotherapy for metastatic non-seminomatous testicular cancer: A quantitative overview of 996 resections
11. Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer
12. Evaluating the yield of medical tests
13. Assessing the fit of the model